The Impact of Health Protection Schemes in Bangladesh

By Staff Writer

January 19, 2024

A Leap Towards Universal Health Coverage

There has been an ongoing issue in Bangladesh for many years, and that is the burden of healthcare expenditure. There has been a substantial rise in out-of-pocket expenditures (OOPE), as seen by the National Health Accounts, which have increased from 63 percent in 2012 to 68.5 percent in 2020. This burden of financial responsibility has led to economic impoverishment, which has resulted in 4.5% of the population falling into poverty on a yearly basis.

As part of its efforts to attain universal health coverage, the World Health Organisation (WHO) promotes for healthcare finance systems that are both inexpensive and accessible. Health insurance programs are one example of such a solution. These programs function as a risk-pooling mechanism that enables individuals to have access to vital medical treatments without the chance of experiencing serious financial difficulties.

Different Models of Health Insurance in Bangladesh

The government of Bangladesh introduced a healthcare finance policy in 2012. The goal was to provide financial protection to all citizens by 2032. The Health Economics Unit of the Ministry of Health and Family Welfare created a health protection program called Shasthyo Surokhsha Karmasuchi (SSK). They designed it as a pilot project for the population below the poverty line in a specific district.

Researchers have evaluated the impact of the SSK program on health status, health service use, occupational health and safety, and financial risk protection. Some studies suggest that insurance boosts utilisation and reduces personal healthcare costs. However, other studies indicate that insurance has a mixed effect or no effect at all.

A Look at the SSK Scheme in Greater Detail

The objective of the SSK plan, which is now being tested in three sub-districts of Tangail District, is to enhance the accessibility of inpatient hospital services for persons living below the poverty line. In addition to providing healthcare services through public hospitals, the scheme also provides extra advantages, such as contracted private pharmacies and clinics for prescription drugs and diagnostic procedures that are not available at the hospitals. The scheme runs as a non-contributory system for the population that falls below the poverty line.

The Effects of the SSK Scheme

The SSK plan has significantly reduced both OOPE and the incidence of catastrophic health expenditures (CHE) in intervention zones. It has also strongly contributed to poverty prevention within these households. However, the scheme’s usage remains low, indicating a need for increased community engagement and motivational efforts. These efforts aim to boost its utilisation among the enrolled Below Poverty Line (BPL) households.

Final Thoughts

The study results show that government-sponsored health protection programs can effectively reduce overall personal medical expenses. This will lead to a decrease in chronic health condition rates, and protection of low-income households. Decision makers can use these findings to adjust the SSK plan before implementing it in other areas. This could speed up the achievement of universal health coverage and sustainable development goals.

Reference url

Recent Posts

DTC telehealth partnerships
           

DTC Telehealth Partnerships: Navigating Risks in Pharma’s Digital Expansion

🚀 Are pharmaceutical companies’ DTC telehealth partnerships reshaping healthcare for better or worse?

Recent findings from the “DTC Investigation 2025” report reveal key insights into the high prescription rates and potential risks of these digital platforms operated by giants like Pfizer and Eli Lilly. Alarmingly, inadequate clinical safeguards raise questions about patient safety, prescribing practices, and cost implications.

Dive into this critical discussion about the intersection of digital health and pharmaceutical practices, and explore what it means for the future of patient care.

#SyenzaNews #DigitalHealth #HealthEconomics #HealthcarePolicy

MAF Test breast cancer
       

MAF Test Breast Cancer: Revolutionizing Personalized Treatment in Spanish Oncology

🌟 How can personalized medicine transform breast cancer treatment in Spain?

The recent rollout of the MAF Test breast cancer in leading Spanish hospitals is set to revolutionize patient care by enabling targeted treatment strategies. This innovative molecular assay not only identifies patients who will benefit from bisphosphonates but also spares those for whom the treatment may be harmful, ultimately improving outcomes for thousands.

Dive into the article to discover how this approach aligns with global trends in oncology and enhances healthcare resource allocation.

#SyenzaNews #precisionmedicine #HealthEconomics #innovation

ribociclib breast cancer guidance
           

NICE’s Ribociclib Breast Cancer Guidance: A New Era for High-Risk Patients in the NHS

🌟 Are we on the brink of transforming breast cancer treatment?

NICE’s latest guidance endorsing ribociclib in combination with an aromatase inhibitor marks a significant advancement for adults facing high-risk early breast cancer. This decision not only promises enhanced survival outcomes but also expands treatment options for patients historically limited to conventional therapies.

Dive into the details of this important development and learn how it may revolutionize patient care in the oncology landscape.

#SyenzaNews #oncology #costeffectiveness #MarketAccess

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER

© 2025 Syenza™. All rights reserved.